2-Amino-4-hydroxy-3-methylpentanoic acid; (2S,3R,4S)-form
AlkaPlorer ID: AK006657
Synonym: '2-Amino-4-hydroxy-3-methylpentanoic acid; (2R,3R,4S)-form'
IUPAC Name: (2S,3R,4S)-2-amino-4-hydroxy-3-methylpentanoic acid
Structure
SMILES: C[C@@H]([C@H](C)O)[C@H](N)C(=O)O
InChI: InChI=1S/C6H13NO3/c1-3(4(2)8)5(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)/t3-,4-,5-/m0/s1
InChIKey: OSCCDBFHNMXNME-YUPRTTJUSA-N
Reference
PubChem CID: 40561613
CAS: 55399-93-4
LOTUS: LTS0078799
SuperNatural Ⅲ: SN0273786-07
NPASS: NPC190385
Source
Properties Information
Molecule Weight: 147.174
TPSA?: 83.55
MolLogP?: -0.5848
Number of H-Donors: 3
Number of H-Acceptors: 3
RingCount: 0
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Homo sapiens | Histone deacetylase 6 | Inhibition | -7.36 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 21.36 | % | 10.6019/CHEMBL4808148 |
| Mesocricetus auratus | Syrian golden hamster | Activity | 4.9 | % | 10.1016/j.bmcl.2005.10.003 |
| Mesocricetus auratus | Syrian golden hamster | Activity | 8.7 | % | 10.1016/j.bmcl.2005.10.003 |
| Mesocricetus auratus | Syrian golden hamster | Activity | 14.0 | % | 10.1016/j.bmcl.2005.10.003 |
| Mesocricetus auratus | Syrian golden hamster | Activity | 22.0 | % | 10.1016/j.bmcl.2005.10.003 |
| Mesocricetus auratus | Syrian golden hamster | Activity | 33.0 | % | 10.1016/j.bmcl.2005.10.003 |
| Mesocricetus auratus | Syrian golden hamster | Ratio | 39.0 | % | 10.1016/j.bmcl.2005.10.003 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 0.1154 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 26.4 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.0 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.19 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 11.94 | % | 10.21203/rs.3.rs-23951/v1 |
| None | No relevant target | Stability | 10.0 | % | 10.1016/j.bmcl.2008.06.081 |
| None | No relevant target | Stability | 32.0 | % | 10.1016/j.bmcl.2008.06.081 |
| None | No relevant target | Stability | 73.0 | % | 10.1016/j.bmcl.2008.06.081 |
| None | Unchecked | Activity | 45.0 | pg/hr | 10.1016/j.bmcl.2008.06.081 |
| None | Unchecked | Activity | 100.0 | pg/hr | 10.1016/j.bmcl.2008.06.081 |
| None | Unchecked | Activity | nan | None | 10.1016/j.bmcl.2008.06.081 |
